| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
 
																	
 
																	Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on dev...
 
																	Reqorsa Gene Therapy is a Potential Treatment for ALK-EML4 Positive Translocated Non-Small Cell Lung CancerCombining REQORSA wi...
 
																	 
																	Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on dev...
 
																	
 
																	As of 12:01 a.m. on October 21, 2025, Genprex, Inc., a Delaware corporation (the "Company"), effected the previously di...
 
																	
